Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Your view on DGX
Overview
What the company does, where it operates, and who runs it.
About Quest Diagnostics Incorporated
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- James E. Davis
- Headquarters
- 500 Plaza Drive, Secaucus, NJ, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- James E. Davis
- Headquarters
- 500 Plaza Drive, Secaucus, NJ, US
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Quest Diagnostics Incorporated from FRC's valuation model, read against the market price. DGX last traded at $262.21, 25.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Quest Diagnostics Incorporated. Starting points for Quest Diagnostics Incorporated: P/E 25.7, EPS $10.26, beta 0.55 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Quest Diagnostics Incorporated. Quest Diagnostics Incorporated paid $3.38 per share over the last year — a 1.3% yield at the current $262.21 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Quest Diagnostics Incorporated. Trailing twelve-month EPS for Quest Diagnostics Incorporated stands at $10.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$249.62
average of 8 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy3
- Hold6
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $2.68 | $2.70 | $11.32 | $11.98 |
| Low estimate | $2.66 | $2.60 | $11.28 | $11.71 |
| High estimate | $2.70 | $2.85 | $11.34 | $12.35 |
| No. of analysts | 10 | 8 | 11 | 11 |
| Year-ago EPS | $2.42 | $2.50 | $8.75 | — |
| Growth | +10.9% | +7.9% | +29.3% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $3.04B | $3.03B | $12.08B | $12.63B |
| Low estimate | $3.01B | $3.00B | $12.06B | $12.55B |
| High estimate | $3.08B | $3.04B | $12.10B | $12.66B |
| No. of analysts | 9 | 7 | 13 | 13 |
| Year-ago revenue | $2.81B | $2.90B | $11.04B | — |
| Growth | +8.4% | +4.6% | +9.5% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Quest Diagnostics Incorporated. Quest Diagnostics Incorporated has reported as a listed company since 1996. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- BMXXYbioMérieux S.A.Medical - Diagnostics & Research$17.2B
- GHGuardant Health, Inc.Medical - Diagnostics & Research$19.5B
- GRALGRAIL, Inc.Medical - Diagnostics & Research$4.7B
- ILMNIllumina, Inc.Medical - Diagnostics & Research$29.9B
- LHLabcorp Holdings Inc.Medical - Diagnostics & Research$30.2B
- NTRANatera, Inc.Medical - Diagnostics & Research$41.8B
- QGENQiagen N.V.Medical - Diagnostics & Research$10.3B
- RDNTRadNet, Inc.Medical - Diagnostics & Research$6.1B
More Medical - Diagnostics & Research companies
- MBGNFMany Bright Ideas Technologies Inc.OTC$101,821
- MDXHMDxHealth S.A.NASDAQ$14M
- MEDDMedical Imaging Corp.OTC$63,819
- MEDPMedpace Holdings, Inc.NASDAQ$18.1B
- MEDVFMedivolve Inc.OTC$54,038
- MRCHFH.U. Group Holdings, Inc.OTC$1.1B
- MRPSMicrophonics, Inc.OTC
- MTDMettler-Toledo International Inc.NYSE$34.4B
- MVF.AXMonash IVF Group LimitedASX
- MYGNMyriad Genetics, Inc.NASDAQ$534M
- NDRAENDRA Life Sciences Inc.NASDAQ$7M
- NEONeoGenomics, Inc.NASDAQ$2.0B
ETFs holding Quest Diagnostics Incorporated
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.04%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.04%
- VOVanguard Mid-Cap ETF$103.4B in assets0.27%
- IVViShares Core SP 500 ETF$852.9B in assets0.04%
- PINKSimplify Health Care ETF$352M in assets3.63%
- IHFiShares US Healthcare Providers ETF$1.5B in assets3.51%
- ZLU.TOBMO Low Volatility US Equity ETF$2.6B in assets1.83%
Largest holders first, then the funds most concentrated in DGX.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Quest Diagnostics Incorporated, and how their positions are changing. At a $28.85B market value, institutional positions materially move Quest Diagnostics Incorporated's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Quest Diagnostics Incorporated executives and directors. Shares of Quest Diagnostics Incorporated have traded between $148.70 and $197.55 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Quest Diagnostics Incorporated. Quest Diagnostics Incorporated is a $28.85B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Quest Diagnostics Incorporated. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Quest Diagnostics Incorporated. Coverage tracks Quest Diagnostics Incorporated within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Quest Diagnostics Incorporated.